| NCT ID | NCT01796171 |
| Title | A Phase I/II Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-01) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Nordic Nanovector |
| Indications | |
| Therapies | |
| Age Groups: | senior adult |